New Medtronic Micra AV pacemaker receives approval from the U.S. FDA
Category: #health  By Saipriya Iyer  Date: 2020-01-23
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

New Medtronic Micra AV pacemaker receives approval from the U.S. FDA

Medtronic plc, a renowned US-based medical device company, reportedly announced that its Micra AV pacemaker has received approval from the U.S. FDA. The Medtronic Micra AV is the world’s smallest pacemaker with AV (atrioventricular) synchrony.

Micra AV pacemaker has been developed to treat patients suffering from AV block. This is a condition in which electrical signals between the heart chambers; the ventricle and the atria, are impaired. The company can now market its first-in-class and the only FDA-authorized leadless pacemaker portfolio, extending the number of potential candidates for this new groundbreaking technology across the U.S.

Cardiac electrophysiologist and Director of NYU Langone’s Heart Rhythm Center, New York City, Larry Chinitz, M.D., stated that with the Micra AV approval, a greater number of pacemaker patients can now qualify for a novel treatment option that delivers the benefits of leadless pacing. Benefits that include a minimally invasive implant process as well as a cosmetically invisible machine.

Chinitz further added that although complications with conventional pacemakers are not frequent, when they occur, they are quite expensive to treat and can also be invasive for a patient. Real-world usage of Micra has demonstrated a 63 percent reduction in bigger complications in comparison with conventional pacemakers.

Traditionally, patients suffering from AV block have received treatment through dual-chamber pacemakers that are implanted surgically in the upper chest, beneath the skin underneath the collar bone, and linked to the heart through a number of thin wires known as leads.

Similar in shape and size to the company’s Micra TPS (Transcatheter Pacing System), Micra AV has many extra internal atrial sensing algorithms that recognize cardiac movement, enabling the device to manage pacing inside the ventricle for further coordination with the atrium, offering AV synchronous pacing treatment to AV block patients.

Chief Medical Officer, Vice President of medical affairs at the Cardiac Rhythm and Heart Failure department, which is a part of the Medtronic Cardiac and Vascular Group, Rob Kowal, M.D., Ph.D. stated that since transforming medicine with the first-in-class cardiac pacemakers powered by battery, the company has continued to innovate better pacing technologies, which has culminated in the leadless pacing and first miniaturized portfolio for patients and physicians.

 

Source credit: http://newsroom.medtronic.com/news-releases/news-release-details/fda-approves-medtronic-micratm-av-worlds-smallest-pacemaker



About Author

Saipriya Iyer

Email: [email protected]   linkdin twitter

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

More News By Saipriya Iyer

 Tabletop Tape Dispensers  market valuation to surge at healthy CAGR through 2026

Tabletop Tape Dispensers market valuation to surge at healthy CAGR through 2026

By Saipriya Iyer

A comprehensive research study on Tabletop Tape Dispensers market added by Market Study Report provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Tabletop Tape D...

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

By Saipriya Iyer

MarketStudyReport.com presents latest report on global General Well-Being Dietary Supplements Market, which evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The re...

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

By Saipriya Iyer

The report Eugenia Jambolana Extract market provides high-quality information regarding the major market trends, product types and their application scope, competitive landscape, and impact of COVID-19 outbreak.

.

Request a...